Shares of Moderna dropped 4.06% to $89.37 at 13:05 EST on Wednesday. The Nasdaq Stock Market jumped 0.25% to $11929.2, on what seems at the moment an all-around somewhat positive exchanging session for Wall Street.
Moderna last close was $93.15, below its 52-week high of $103.2.
Moderna’s sales growth is 1074.4% for the current quarter and 2299% for the next. The company’s growth estimates for the current quarter and the next is a negative 73% and a positive 142.9%, respectively.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s stock is valued at $89.37 at 18:05 EST, way below its 52 Week High of $103.2 and way higher than its 52 Week Low of $17.68.
Moderna’s value is way above its 50 day moving average of $74.25.
Moderna’s worth is way higher than its 200 day moving average of $68.61.